Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02570711
Title Study of Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Previously Untreated Metastatic Pancreatic Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Acerta Pharma BV
Indications

pancreatic adenocarcinoma

Therapies

Acalabrutinib

Gemcitabine + Nab-paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.